Males but not females show differences in calbindin immunoreactivity in the dorsal thalamus of the mouse model of fragile X syndrome

Journal of Comparative Neurology

Volumn 521, Issue 4, 2013, Pages 894-911

  Giráldez Pérez, Rosa M ^a   Ávila, M Nieves ^a   Feijóo Cuaresma, Mónica ^a   Heredia, Raúl ^b   De Diego Otero, Yolanda ^b   Real, M Ángeles ^a   Guirado, Salvador ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Calcium binding proteins; Calretinin; FMRP; Immunohistochemistry; Models of disease; Parvalbumin

Indexed keywords

CALBINDIN; CALRETININ; PARVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THALAMUS; THALAMUS INTRALAMINAR NUCLEUS; THALAMUS MIDLINE NUCLEUS; THALAMUS POSTERIOR NUCLEUS; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DISEASE MODELS, ANIMAL; FEMALE; FRAGILE X SYNDROME; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; SEX CHARACTERISTICS; THALAMUS;

EID: 84872733365     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23209     Document Type: Article

References (79)

1. Abel JM, Witt DM, Rissman EF. 2011. Sex differences in the cerebellum and frontal cortex: roles of estrogen receptor alpha and sex chromosome genes. Neuroendocrinology 93: 230-240.
2. Akins MR, Berk-Rauch HE, Fallon JR. 2009. Presynaptic translation: stepping out of the postsynaptic shadow. Front Neural Circuits 3: 17.
3. Andressen C, Blumcke I, Celio MR. 1993. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 271: 181-208.
4. Arai R, Jacobowitz DM, Deura S. 1994. Distribution of calretinin, calbindin-D28k, and parvalbumin in the rat thalamus. Brain Res Bull 33: 595-614.
5. Baimbridge KG, Celio MR, Roger JH. 1992. Calcium-binding proteins in the nervous system. Trends Neurosci 15: 303-308.
6. Bassell GJ, Warren ST. 2008. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60: 201-214.
7. Battaglia G, Colacitti C, Bentivoglio M. 1992. The relationship of calbindin-containing neurons with substance P, Leu-enkephalin and cholecystokinin fibres: an immunohistochemical study in the rat thalamus. J Chem Neuroanat 5: 453-464.
8. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci 27: 370-377.
9. Bearzatto B, Servais L, Roussel C, Gall D, Baba-Aïssa F, Schurmans S, de Kerchove d'Exaerde A, Cheron G, Schiffmann SN. 2006. Targeted calretinin expression in granule cells of calretinin-null mice restores normal cerebellar functions. FASEB J 20: 380-382.
10. 2+ sensor. J Biol Chem 277: 16662-16672.
11. Blasco B, Avendaño C, Cavada C. 1999. A stereological analysis of the lateral geniculate nucleus in adult Macaca nemestrina monkeys. Vis Neurosci 16: 933-941.
12. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
13. Celio MR. 1990. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35: 375-475.
14. Celio MR, Baier W, Schärer L, Gregersen HJ, de Viragh PA, Norman AW. 1990. Monoclonal antibodies directed against the calcium binding protein calbindin D-28k. Cell Calcium 11: 599-602.
15. Christie SB, Akins MR, Schwob JE, Fallon JR. 2009. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J Neurosci 29: 1514-1524.
16. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough, WT. 1997. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A 94: 5401-5404.
17. Darnell JC, Van Driesche SJ, Zhang C, Hung KYS, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB. 2011. FMRP stall ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146: 247-261.
18. De Biasi S, Arcelli P, Spreafico R. 1994. Parvalbumin immunoreactivity in the thalamus of guinea pig: light and electron microscopic correlation with gamma-aminobutyric acid immunoreactivity. J Comp Neurol 348: 556-569.
19. De Diego-Otero Y, Romero-Zerbo Y, Rajaa el B, Decara J, Sanchez L, Rodríguez-de Fonseca F, del Arco-Herrera I. 2009. α-Tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. Neuropsychopharmacology 34: 1011-1026.
20. De Vries BB, Wiegers AM, Smits AP, Mohkamsing S, Duivenvoorden HJ, Fryns JP, Curfs LM, Halley DJ, Oostra BA, van den Ouweland AM, Niermeijer MF. 1996. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 58: 1025-1032.
21. Deng P-Y, Sojka D, Klyachko VA. 2011. Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. J Neurosci 31: 10971-10982.
22. Dölen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF. 2007. Correction of fragile X syndrome in mice. Neuron 56: 955-962.
23. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, Tada T, Dolan BM, Sharp PA, Sheng M. 2010. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Erratum in: Neuron 65: 373-384.
24. Ekstrand JJ, Domroese ME, Feig SL, Illig KR, Haberly LB. 2001. Immunocytochemical analysis of basket cells in rat piriform cortex. J Comp Neurol 434: 308-328.
25. Franklin KBJ, Paxinos G. 2007. The mouse brain in stereotaxic coordinates, 3rd ed. San Diego: Academic Press.
26. Frassoni C, Bentivoglio M, Spreafico R, Sánchez MP, Puelles L, Fairen A. 1991. Postnatal development of calbindin and parvalbumin immunoreactivity in the thalamus of the rat. Brain Res Dev Brain Res 58: 243-249.
27. Fuentealba P, Klausberger T, Karayannis T, Suen WY, Huck J, Tomioka R, Rockland K, Capogna M, Studer M, Morales M, Somogyi P. 2010. Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus. J Neurosci 30: 1595-1609.
28. Gall D, Roussel C, Susa I, D'Angelo E, Rossi P, Bearzatto B, Galas MC, Blum D, Schurmans S, Schiffmann SN. 2003. Altered neuronal excitability in cerebellar granule cells of mice lacking calretinin. J Neurosci 23: 9320-9327.
29. Gall D, Roussel C, Nieus T, Cheron G, Servais L, D'Angelo E, Schiffmann SN. 2005. Role of calcium binding proteins in the control of cerebellar granule cell neuronal excitability: experimental and modeling studies. Prog Brain Res 148: 321-328.
30. Gatto C, Broadie K. 2008. Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure. Development 135: 2637.
31. Ghosh A, Ginty DD, Bading H, Greenberg ME. 1994. Calcium regulation of gene expression in neuronal cells. J Neurobiol 25: 294-303.
32. Gibson JR, Bartley AF, Hays SA, Huber KM. 2008. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol 100: 2615-2626.
33. Gold JJ, Squire LR. 2006. The anatomy of amnesia: neurohistological analysis of three new cases. Learn Mem 13: 699-710.
34. Gonzalo-Ruiz A, Lieberman AR. 1995. GABAergic projections from the thalamic reticular nucleus to the anteroventral and anterodorsal thalamic nuclei of the rat. J Chem Neuroanat 9: 165-174.
35. Gundersen HJ, Bagger P, Brendtsen TF, Evans SM, Korbo L, Marcussen L, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B. 1988. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. AMPIS 96: 857-881.
36. Gutierrez C, Yaun A, Cusick CG. 1995. Neurochemical subdivisions of the inferior pulvinar in macaque monkeys. J Comp Neurol 363: 545-562.
37. Hagerman RJ. 2002. The physical and behavioural phenotype. In: Fragile X syndrome: diagnosis, treatment and research. Baltimore: Johns Hopkins University Press. p 3-109.
38. Hagerman RJ, Jackson C, Amiri K, Silverman AC, O'Connor R, Sobesky W. 1992. Girls with fragile X syndrome: physical and neurocognitive status and outcome. Pediatrics 89: 395-400.
39. Huber KM, Gallagher SM, Warren ST, Bear MF. 2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A 99: 7746-7750.
40. Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DE, Heizmann CW. 1988. Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res 475: 156-159.
41. Jacobowitz, DM, Winsky, L. 1991. Immunocytochemical localization of calretinin in the forebrain of the rat. J Comp Neurol 304: 198-218.
42. Jones, EG, Hendry, SHC. 1989. Differential calcium-binding protein immunoreactivity distinguishes classes of relay neurons in monkey thalamic nuclei. Eur J Neurosci 1: 222-245.
43. Katz B, Miledi R. 1967. Ionic requirements of synaptic transmitter release. Nature 215: 651.
44. Kelleher RJ, Bear MF. 2008. The autistic neuron: troubled translation? Cell 135: 401-406.
45. Kubota Y, Jones EG. 1993. Co-localization of two calcium binding proteins in GABA cells of rat piriform cortex. Brain Res 600: 339-344.
46. Lu E, Llano DA, Sherman SM. 2009. Different distributions of calbindin and calretinin immunostaining across the medial and dorsal divisions of the mouse medial geniculate body. Hear Res 257: 16-23.
47. Magloczky Z, Halasz P, Vajda J, Czirják S, Freund TF. 1997. Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience 76: 377-385.
48. 2+ currents in thalamocortical relay neurons. Pflugers Arch 450: 111-122.
49. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, Liu L, Carbonetto S, Weiler IJ, Greenough WT, Eberwine J. 2003. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37: 417-431.
50. Miyata S, Nakai S, Kiyohara T, Hatton GI. 2000. Calbindin-D28k and calretinin in the rat posterior pituitary; light and electron microscopic localization and upregulation with dehydration. J Neurocytol 29: 5-17.
51. Molinari M, Leggio MG, Dell'Anna ME, Giannetti S, Macchi G. 1994. Chemical compartmentation and relationships between calcium-binding protein immunoreactivity and layer-specific cortical caudate-projecting cells in the anterior intralaminar nuclei of the cat. Eur J Neurosci 6: 299-312.
52. Münkle MC, Waldvogel HJ, Faull RL. 2000. The distribution of calbindin, calretinin and parvalbumin immunoreactivity in the human thalamus. J. Neuroanat 19: 155-173.
53. Olmos-Serrano JL, Corbin JG. 2011. Amygdala regulation of fear and emotionality in Fragile X syndrome. Dev Neurosci 33: 365-378.
54. Olmos-Serrano JL, Paluszkiewicz SM, Martin BS, Kaufmann WE, Corbin JG, Huntsman MM. 2010. Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 30: 9929-9938.
55. Penagarikano O, Mulle JG, Warren ST. 2007. The pathophysiology of fragile X syndrome. Annu Rev Genomics Hum Genet 8: 109-129.
56. Qin M, Kang J, Burlin TV, Jiang C, Smith CB. 2005. Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. J Neurosci 25: 5087-5095.
57. Real MA, Simón MP, Heredia R, de Diego Y, Guirado S. 2011. Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice. J Comp Neurol 519: 2622-2636.
58. Résibois A, Rogers JH. 1992. Calretinin in rat brain: an immunohistochemical study. Neuroscience 46: 101-134.
59. Reynolds GP, Abdul-Monim Z, Neill JC, Zhang ZJ. 2004. Calcium binding protein markers of GABA deficits in schizophrenia-postmortem studies and animal models. Neurotox Res 6: 57-61.
60. Rogers JH, Résibois A. 1992. Calretinin and calbindin-D28k in rat brain: patterns of partial co-localization. Neuroscience 51: 843-865.
61. Roper SN, Eisenschenk S, King MA. 1999. Reduced density of parvalbumin- and calbindin D28-immunoreactive neurons in experimental cortical dysplasia. Epilepsy Res 37: 63-71.
62. Rostkowski AB, Teppen TL, Peterson DA, Urban JH. 2009. Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala. J Comp Neurol 517: 166-176.
63. Schiffmann SN, Cheron G, Lohof A, d'Alcantara P, Meyer M, Parmentier M, Schurmans S. 1999. Impaired motor coordination and Purkinje cell excitability in mice lacking calretinin. Proc Natl Acad Sci U S A 96: 5257-5262.
64. Schmidt H, Schwaller B, Eilers J. 2005. Calbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons. Proc Natl Acad Sci U S A 102: 5850-5585.
65. Schwaller B, Buchwald P, Blümcke I, Celio MR, Hunziker W. 1993. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium 14: 639-648.
66. Schwaller B, Brückner G, Celio MR, Härtig W. 1999. A polyclonal goat antiserum against the calcium-binding protein calretinin is a versatile tool for various immunochemical techniques. J Neurosci Methods 92: 137-144.
67. Schwaller B, Meyer M, Schiffmann S. 2002. New functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 1: 241-258.
68. Sterio DC. 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134: 127-136.
69. Suvrathan A, Chattarji S. 2011. Fragile X syndrome and the amygdala. Curr Opin Neurobiol 21: 509-515.
70. Suvrathan A, Tomar A, Chattarji S. 2010. Effects of chronic and acute stress on rat behaviour in the forced-swim test. Stress 13: 533-540.
71. Tessier CR, Broadie K. 2011. The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons. Neurobiol Dis 41: 147-159.
72. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. 2005. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57: 252-260.
73. Velayos JL, Jiménez-Castellanos J Jr, Reinoso-Suárez F. 1989. Topographical organization of the projections from the reticular thalamic nucleus to the intralaminar and medial thalamic nuclei in the cat. J Comp Neurol 279: 457-469.
74. Vig PJ, Subramony SH, Burright EN, Fratkin JD, McDaniel DO, Desaiah D, Qin Z. 1998. Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology 50: 106-113.
75. Wang J, Huo FQ, Li YQ, Chen T, Han F, Tang JS. 2005. Thalamic nucleus submedius receives GABAergic projection from thalamic reticular nucleus in the rat. Neuroscience 134: 515-523.
76. Winsky L, Nakata H, Martin BM, Jacobowitz DM. 1989. Isolation, partial amino acid sequence, and immunohistochemical localization of a brain-specific calcium-binding protein. Proc Natl Acad Sci U S A 86: 10139-10143.
77. Winsky L, Montpied P, Arai R, Martin BM, Jacobowitz DM. 1992. Calretinin distribution in the thalamus of the rat: immunohistochemical and in situ hybridization histochemical analyses. Neuroscience 50: 181-196.
78. Zhang YQ, Bailey AM, Matthies HJ, Renden RB, Smith MA, Speese SD, Rubin GM, Broadie K. 2001. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107: 591-603.
79. Zhang C, Szabó G, Erdélyi F, Rose JD, Sun QQ. 2006. Novel interneuronal network in the mouse posterior piriform cortex. J Comp Neurol 499: 1000-1015.